{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:19:42Z","timestamp":1720570782443},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ad.2023.03.019","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T08:53:43Z","timestamp":1707296023000},"page":"T427-T429","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] The Utility of long-Term Number Needed to Treat to Evaluate Interleukin 17 and 23 Inhibitor Therapies in the Treatment of Moderate to Severe Plaque Psoriasis"],"prefix":"10.1016","volume":"115","author":[{"given":"A.","family":"Gonz\u00e1lez-Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Garc\u00eda-Agua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dauden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ventayol-Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2023.03.019_bib0040","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","article-title":"An assessment of clinically useful measures of the consequences of treatment","volume":"318","author":"Laupacis","year":"1988","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2023.03.019_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ."},{"key":"10.1016\/j.ad.2023.03.019_bib0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ad.2021.10.003","volume":"113","author":"Carrascosa","year":"2022","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas."},{"key":"10.1016\/j.ad.2023.03.019_bib0055","unstructured":"REvalMed SNS. Comisi\u00f3n Permanente de Farmacia del Consejo Interterritorial del SNS. Procedimiento normalizado de trabajo de evaluaci\u00f3n cl\u00ednica, evaluaci\u00f3n econ\u00f3mica y posicionamiento terap\u00e9utico para la redacci\u00f3n de Informes de Posicionamiento Terap\u00e9utico de medicamentos en el Sistema Nacional de Salud [Internet]. 2020 [consultado 18 Feb 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/farmacia\/IPT\/docs\/20200708.PNT_elaboracion_IPT_CPF8Julio.pdf"},{"key":"10.1016\/j.ad.2023.03.019_bib0060","unstructured":"Ministerio de Sanidad. Listado de Medicamentos afectados por las deducciones del RD 8\/2010 [consultado 30 Ene 2022]. Disponible en: http:\/\/www.mscbs.gob.es\/en\/profesionales\/farmacia\/notasInfor.htm"},{"key":"10.1016\/j.ad.2023.03.019_bib0065","unstructured":"Consejo General de Colegios Farmace\u00faticos. BOT Plus 2.0. Base de Datos de Medicamentos [Internet] 2022 [consultado 17 Mar 2022]. Disponible en: https:\/\/botplusweb.portalfarma.com\/"},{"key":"10.1016\/j.ad.2023.03.019_bib0070","unstructured":"CIMA: Centro de informaci\u00f3n de medicamentos [Internet]. 2021 [consultado 17 Mar 2022]. Disponible en: https:\/\/cima.aemps.es\/cima\/publico\/home.html"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024000917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024000917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T12:45:05Z","timestamp":1720529105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731024000917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0001731024000917"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2023.03.019","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] The Utility of long-Term Number Needed to Treat to Evaluate Interleukin 17 and 23 Inhibitor Therapies in the Treatment of Moderate to Severe Plaque Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.03.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}